Tudor Investment Corp’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,183
| Closed | -$38.2K | – | 1483 |
|
|
2024
Q3 | $38.2K | Hold |
33,183
| – | – | ﹤0.01% | 1485 |
|
|
2024
Q2 | $36.5K | Hold |
33,183
| – | – | ﹤0.01% | 1437 |
|
|
2024
Q1 | $41.1K | Hold |
33,183
| – | – | ﹤0.01% | 1390 |
|
|
2023
Q4 | $34.8K | Hold |
33,183
| – | – | ﹤0.01% | 1400 |
|
|
2023
Q3 | $227K | Buy |
33,183
+1
| +0% | +$7 | ﹤0.01% | 1300 |
|
|
2023
Q2 | $344K | Buy |
33,182
+2,038
| +7% | +$21.1K | ﹤0.01% | 1232 |
|
|
2023
Q1 | $252K | Buy |
+31,144
| New | +$252K | ﹤0.01% | 1321 |
|
|
2022
Q3 | – | Sell |
-12,090
| Closed | -$169K | – | 1540 |
|
|
2022
Q2 | $169K | Buy |
+12,090
| New | +$169K | ﹤0.01% | 1405 |
|
|
2021
Q4 | – | Sell |
-10,539
| Closed | -$190K | – | 1563 |
|
|
2021
Q3 | $190K | Buy |
+10,539
| New | +$190K | ﹤0.01% | 1436 |
|
|
2020
Q4 | – | Sell |
-20,750
| Closed | -$53K | – | 1280 |
|
|
2020
Q3 | $53K | Sell |
20,750
-37,976
| -65% | -$97K | ﹤0.01% | 1196 |
|
|
2020
Q2 | $95K | Hold |
58,726
| – | – | ﹤0.01% | 1080 |
|
|
2020
Q1 | $61K | Sell |
58,726
-200
| -0.3% | -$208 | 0.01% | 955 |
|
|
2019
Q4 | $111K | Hold |
58,926
| – | – | 0.01% | 1039 |
|
|
2019
Q3 | $64K | Buy |
+58,926
| New | +$64K | ﹤0.01% | 1010 |
|
|
2019
Q1 | – | Sell |
-12,906
| Closed | -$95K | – | 1069 |
|
|
2018
Q4 | $95K | Buy |
+12,906
| New | +$95K | ﹤0.01% | 916 |
|
|
2018
Q1 | – | Sell |
-12,296
| Closed | -$303K | – | 957 |
|
|
2017
Q4 | $303K | Buy |
+12,296
| New | +$303K | 0.01% | 788 |
|